Blue Jet Healthcare Limited (NSEI: BLUEJET)
Health Care · Pharmaceuticals · IN
Rs584.50
-1.58% today · -25.2% 1Y
Blue Jet Healthcare Limited (NSEI: BLUEJET) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.16B and employs 447 people.
Over the last twelve months the share price has lost 25.2%, trading between 325.00 and 792.00.
Tweenvest scores Blue Jet Healthcare Limited across four factors: quality 73/100, value 33/100, growth 19/100, dividend 39/100. Its strongest factor is quality.
BLUEJET price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.16B
- Revenue (TTM)
- $93.67M
- P/E
- 43.17
- EPS
- 13.54
- Dividend yield
- 0.21%
- Beta (5Y)
- 0.64
- 52-week high
- Rs792.00
- 52-week low
- Rs325.00
- Avg volume (3M)
- —
- Shares outstanding
- 189.28M
- Employees
- 447
- Next earnings
- —
About Blue Jet Healthcare Limited
Blue Jet Healthcare Ltd. is a company that focuses on the manufacturing and supply of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), which are critical components for the pharmaceutical and healthcare sectors. Its product offerings include integrated intermediates used in contrast media, saccharin and its associated salts, and a range of specialized pharmaceutical intermediates and APIs. The company also delivers comprehensive contract development and manufacturing (CDMO/CMO) and development services. Founded in 1968, Blue Jet Healthcare is headquartered in Thane, India, and maintains a broad international operational footprint across countries such as India, Norway, the United States, Sweden, Italy, and Spain.
- ISIN
- INE0KBH01020
- Founded
- 1968
- Listed since
- Nov 1, 2023
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,217.60 | -1.30% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.62 | -0.56% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.85 | -1.02% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.20 | -1.50% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.46 | -1.84% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.96% |
Figures last refreshed Aug 18, 2026.